Scientists at Washington State University, USA, have conducted a clinical trial to investigate the acute effect of cannabigerol on anxiety, stress, and mood in healthy individuals. They have published ...
Cannabigerol (CBG) has significant potential to treat neurological disorders according to a recent study published in Pharmaceuticals. The Penn State research team determined that CBG can be a ...
CBG (Cannabigerol) was first discovered in the 1960s and is the originator from which all cannabinoids were created. This exclusive remedy is promised to provide enormous therapeutic results. This ...
Phytoplant Research participated in a first-ever pioneering collaborative project to investigate the ability of cannabinoid cannabigerol (CBG), the molecular precursor of Δ9-tetrahydrocannabinol (Δ ...
In a recent study published in Scientific Reports, researchers conducted a placebo-controlled, double-blind crossover field trial to examine whether the phytocannabinoid cannabigerol impacted mood, ...
Rockville, May 25, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global cannabigerol market is expected to reach US$ 60.84 billion by the end ...
COLUMBIA, Md., June 07, 2022 (GLOBE NEWSWIRE) -- Neon Bloom, Inc. (OTC: NBCO): Bazelet Health Systems™, a wholly owned subsidiary of Neon Bloom, is proud to announce the endowment of a program known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback